share_log

MannKind Price Target Announced at $8.00/Share by Leerink Partners

MannKind Price Target Announced at $8.00/Share by Leerink Partners

曼恩凯德生物医疗的股价目标被Leerink Partners宣布为8.00美元/股。
道琼斯 ·  09/09 08:56  · 评级/大行评级

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发